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EDITORIAL REVIEW
Role of dietary factors in the progression of chronic
renal disease
In diseases of the kidney characterized by irreversible injury,
it appears that once a critical level of renal functional deteriora-
tion is reached, progression to endstage disease invariably
occurs even if the initiating event or condition is resolved or
eradicated. Immunopathogenetic mechanisms probably ac-
count for most forms of primary glomerular disease in humans.
Although immunologic events and the mediators of glomerular
damage that they induce might be responsible for initiating most
glomerular diseases, certain clinical and experimental observa-
tions suggest that the rate of progression of these diseases is
influenced by several nonimmunologic factors. In certain dis-
eases, such as proliferative glomerulonephritis, the relentless
decrease in renal function is due very likely to the initial
underlying process; in other entities characterized mainly by
interstitial scarring and glomerular sclerosis, the cause of pro-
gressive loss of renal function is less apparent. Recent experi-
mental evidence suggests that dietary manipulations, such as
reductions in protein and/or phosphate intake, can halt or
attenuate the progression of chronic renal insufficiency in
experimental animal models. Therefore, the exciting possibility
exists that the natural history of some renal diseases may be
altered by changes in the diet. We review current information
regarding the role of manipulations of dietary protein, phospho-
rus, or lipid content on the progression of chronic renal disease.
Most of the experimental observations to be reviewed have
been made in animal models of renal disease. The literature on
the role of dietary manipulations on the progression of renal
disease in patients is somewhat limited and will not be empha-
sized here.
Role of protein intake
The observation that ingestion of protein aggravates the
clinical condition of patients with renal insufficiency dates back
to the turn of the century. Ambard [1] noted that uremic
patients are often wasted and do poorly, particularly when they
ingest meat. The clinical experience led to efforts to alleviate
"toxicity of uremia" by reducing dietary intake of protein.
Volhard 121 wrote that "in cases with chronic renal insufficien-
cy, a reduction in nitrogen intake to levels of 3—5 grams per day
(about 20—30 grams of protein) prevents the rise in blood urea
for long periods of time; . . . considerably elevated urea,
indican and xanthoprotein values decrease and initial signs of
uremic intoxication disappear." These observations, and many
others since, have clearly established that a reduction in protein
intake ameliorates many manifestations of the uremic syndrome
[3—61.
Less well appreciated, until the last 3 or 4 years, is the
substantial literature of the previous six decades related to the
potential harmful effects of dietary protein on renal function in
normal animals or animals after nephrectomy. Interest in this
area has been rekindled, in great measure, by the elegant and
provocative studies of Brenner, Meyer, and Hostetter [7] and
Brenner [8] regarding the potential mechanisms by which
protein intake may affect the progression of renal disease.
Effect of dietary protein on renal function and structure in
experimental animals
In 1919 and 1923 Newburgh [9] and Newburgh and C .rkson
[101 reported the production of renal structural damage in
rabbits fed diets containing large amounts of protein. These
experiments were criticized on four scores: (1) The frequent
spontaneous occurrence of renal lesions in the rabbit made it
difficult to prove that any given injury was caused by the
experimental procedure; (2) the herbivorous rabbit, habituated
to a diet low in protein, was a poor test animal; (3) the diets
were nutritionally inadequate; (4) the lesions were due to the
acidity of the urine in an animal which normally excretes an
alkaline urine. In reply to these criticisms Newburgh and Curtis
[111 in 1928 reported the development of similar lesions in white
rats fed "adequate" diets, containing varying kinds of protein.
Further, both the quantity and "quality" of dietary protein
seemed important in the development of renal disease. Rats fed
diets containing 75% dry liver developed renal lesions in less
than 1 year, but the same amount of casein fed for 16 months
caused only moderate tubular injury. A diet containing protein
from beef muscle was intermediate in its renal effects.
In the l920s Osborne et al [12, 13] reported that renal
hypertrophy occurred consistently in rats fed a diet in which
protein intake exceeded about one third of the "food fuel in the
ration." This renal response was found with all proteins tested
but not with equivalent amounts of urea [131. Neither Osborne
et al [131 or Jackson and Riggs [14] found evidence of renal
disease in their rats fed high protein diets. Berg and Simms [15,
16] showed later that rats receiving a moderately restricted diet
(54% of ad libitum food intake) lived longer and had a lower
incidence of degenerative disease than animals fed ad libitum.
The combined incidence of renal, vascular, and myocardial
lesions in males fed a restricted diet increased with advancing
age from 24% at 800 days of age to 60% at 900 days and to 75%
at 1100, but the frequency of lesions in males fed an ad libitum
diet was 100% at 800 and 900 days. In females fed a restricted
diet, the combined incidence of renal, vascular or myocardial
lesions was zero at 800 days and 24% at 1100 days as compared
with 60 and 90% in rats fed ad libitum. Thus, onset of disease
was earlier, and incidence and severity of lesions were greater
in males than in females both on a restricted or ad libitum food
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intake. These studies indicate that partial dietary restriction of
all nutrients in rats in captivity markedly delays the develop-
ment of renal lesions.
Numerous investigators have reported a deleterious effect of
dietary protein on the course of experimental nephritis and on
the progressive renal failure that occurs after subtotal renal
ablation. On balance the available evidence indicates that high
protein intake accelerates the progression of renal insufficiency
in both models. Moise and Smith [17] found that renal lesions
develop rapidly in uninephrectomized rats eating a high protein
diet. Chanutin and Ludewig [181 varied the dietary protein of
partially nephrectomized rats from 10 to 80% and found that the
degree of proteinuria, the severity of renal insufficiency, and
mortality increased progressively with high dietary protein.
Lalich and Allen [19] found excessive proteinuria followed by
structural changes and eventual sclerosis of glomeruli in unin-
ephrectomized rats fed diets containing 30% protein. In 1939,
Farr and Smadel [20, 21] reported that in rats with nephrotoxic
serum nephritis fed a 5% protein diet, clinical renal disease
subsided rapidly and glomerular and tubular injury resolved. By
contrast, rats fed a diet containing 40% protein uniformly
developed renal failure and died within 1 year. It should be
noted that the low protein diet (5%) used in the studies of Farr
and Smadel is insufficient to sustain growth or maintain a
nitrogen balance in rats. This is also the case in several other
studies which have employed extremely low protein, phosphate
or fatty acid intakes (see below). In such instances growth
impairment, negative nitrogen balance, osteomalacia, phos-
phate depletion, and malnutrition may represent a poor trade off
for delaying the progression of chronic renal disease.
Dubois and Strain [22] first demonstrated a beneficial effect
of diet (low phenylalanine and low tyrosine) on survival and
nephropathy of a mouse model of systemic lupus (NZB-NZW
Fl mice). Subsequently, Friend et al [23] reported that NZB
and NZW F1 mice initiated on calorie restriction when weaned,
at 4 to 5 months of age, or fed a moderately restricted protein
intake at weaning were afforded significant protection from the
development of immune nephritis. These findings suggest that
diet may influence the course of autoimmune disease and
associated immune complex nephritis even after the onset of
serologic abnormalities and tissue injury. In 1937 Medlar and
Blatherwick [24, 25] and in 1957 Kennedy [26] suggested that
glomerular sclerosis occurring with aging, uninephrectomy, or
both could be accelerated by high protein feeding in rats.
Wachtel, Cole, and Rosen [27] showed that the rapidity and
severity of the glomerular sclerosis that occurs in weanling rats
after irradiation were increased by unilateral nephrectomy and
were slowed by retardation of renal growth produced by low
food intake. Ritz et al [28] fed rats that were made uremic by
partial nephrectomy and irradiation of the remaining parenchy-
ma diets containing either 51% protein with 3% fat; 14.5%
protein, 3% fat; or 17.5% protein with 20% fat. All rats fed the
high protein diet were dead 11 days after partial renal ablation.
By contrast, most animals fed a high fat diet and 75% of the rats
fed a high carbohydrate diet were alive 30 days after surgery
and irradiation. More recently, Kleinknecht et al [29] examined
the effects of various protein diets on growth, renal function,
and survival in Wistar rats with 85% renal ablation. A diet
containing 37% protein led to anorexia, growth failure, and
rapid deterioration of renal function in these rats.
All of the above studies indicated an important deleterious
role for protein in the progression of renal insufficiency; howev-
er, since the content of sodium, phosphate, and calcium was
higher in the high protein diets, an exclusive role of protein was
not established.
The mechanism by which high protein intake accelerates the
development and severity of glomerular sclerosis in animals
with experimental nephritis, with subtotal renal ablation or during
aging, is unclear. Studies in the 1930s showed that urea clear-
ance, GFR, and renal blood flow could be acutely increased
two- to threefold in the dog by high protein feeding [30—32].
Higher inulin-clearance values were found in rats fed 40%
casein than in rats fed 6% casein [33]. Pennell et al [34] also
found decreased GFR values in weanling rats fed a low protein
diet. Protein restriction in these weanling rats reduced kidney
mass, which may have been the main factor responsible for the
decrease in GFR. Lower GFR and renal plasma flow values
were reported in sheep fed a low protein diet (4.9%) as
compared to sheep fed a high protein diet (14.9%) [35]. Ichika-
wa et al [36] found lower values for glomerular capillary plasma
flow and Kf in rats fed a low protein diet than in rats fed a high
protein diet. The fall in glomerular capillary plasma flow rate
was due to increased afferent and efferent arteriole resistances.
The rats fed a low protein diet also had a reduction in glomeru-
lar cross sectional area which accounted, at least partially, for
the decline in Kf.
A potential role for increased glomerular perfusion and
hyperfiltration in the causation of glomerular sclerosis has been
suggested from studies performed in an experimental model of
uremia produced by partial infarction or resection of one kidney
and contralateral nephrectomy. Chanutin and Ferris [37] first
described in 1932, to our knowledge, that this rat model
developed proteinuria, hypertension, and progressive renal
disease, an observation confirmed subsequently by other inves-
tigators [38—40]. Dog studies from our laboratory [41] demon-
strated that glomerular hyperfiltration and hyperperfusion oc-
cur as renal mass is reduced. These observations were con-
firmed subsequently in the rat [42]. The extent of functional
adaptation is proportional to the amount of renal mass removed
and more extensive renal ablation results in a greater increase in
single nephron GFR [43]. Micropuncture studies 1 week after a
90% reduction of renal mass [441 in Munich-Wistar rats indicate
that the increase in single nephron GFR to values about twice
those seen in normal rats is due to a striking increase in
glomerular plasma flow rate and an increased glomerular trans-
capillary hydraulic pressure gradient. Arteriolar vasodilatation,
rather than major increments in systemic arterial pressure, was
responsible for the increase in glomerular capillary hydraulic
pressure. Although the increments in single nephron GFR and
its determinants observed 3 weeks after unilateral nephrectomy
were less extreme [45], these changes were in the same direc-
tion as those seen after greater reductions in renal mass. In
conjunction with this increase in GFR in the remnant kidney,
there were striking structural alterations. All three glomerular
cell types showed abnormalities. However, changes in the
epithelial cells were the most remarkable. Two weeks after
renal ablation, adhesions of epithelial cells to Bowman's cap-
sule were seen in severely involved glomeruli. In some areas,
epithelial cells were detached from the underlying basement
membrane. All glomeruli showed a prominent increase in
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mesangial cells and matrix [44, 46]. Despite the reduction in
total GFR, the absolute excretion of protein, primarily albumin
by the remnant kidneys, was increased. Studies of fractional
clearances of neutral dextrans [46] and PVP [47] demonstrated
alterations in the size selective properties of glomerular capil-
laries in remnant kidneys. Fractional clearances of anionic,
neutral, and cationic horseradish peroxidases and of dextran
sulfates revealed a reduction in charge selective properties [46].
Since albumin is a polyanion protein, defects in the charge
selectivity of glomeruli in the remnant kidney will contribute to
the development of albuminuria.
A close linkage between glomerular hyperfiltration and struc-
tural changes was suggested in studies involving dietary protein
restriction. Feeding a low protein diet to rats with remnant
kidneys largely prevents the striking increase in glomerular
plasma flow and capillary pressures which leads to hyperfiltra-
tion. Also the accompanying proteinuria and structural alter-
ations of epithelial cells are less severe [44, 46]. It has been
proposed that the progression of chronic renal insufficiency
after a critical reduction in renal mass may be actively depen-
dent on a final common pathway: glomerular hyperfiltration [7].
As the functional contribution of the scierosing glomeruli is
lost, less severely affected glomeruli undergo further compensa-
tory hyperfiltration with subsequent injury, favoring progres-
sion and eventual total loss of glomeruli.
Although these studies [44, 46] provide a logical explanation
for a relationship between dietary protein intake and the
progressive loss of renal function, the mechanisms by which a
low protein diet attenuates the progression of renal disease have
not been clarified completely. More work is necessary to
establish the fact that hyperfiltration" constitutes the major
link between excessive dietary protein intake and glomerular
pathology. It is possible that changes in dietary protein may
affect the levels of vasoconstrictor and/or vasodilatory sub-
stances produced by the kidney, the levels of serum lipids, and
the secretion and/or glomerular response to a number of hor-
mones 148]. These and other effects of dietary protein on the
kidney, as yet not described, may contribute to the progression
of renal disease. However, it seems clear from these studies in
experimental animals that excessive dietary protein accelerates
the functional deterioration in chronic renal disease. Additional
work is required to clarify the mechanisms by which restriction
of protein intake modifies the progression of renal disease in
certain experimental animal models. It is also clear, however,
that guidelines need to be established and more information is
required as to the safe limits for protein restriction. To what
extent can protein intake be restricted to obtain maximal effects
on the progression of renal disease, but without impairing
growth and/or producing prolonged negative nitrogen balance
and malnutrition?
Other maneuvers, besides protein restriction, can affect the
progression of renal disease in rats with subtotal nephrectomy.
Harter, Davis, Tegtmeyer, and Karl (unpublished observations)
found that endurance exercise training decreased BUN signifi-
cantly (31.2 1.9 mg/dl vs. 46 6.0 mg/dl) and serum
creatinine (0.57 0.04 vs. 0.72 0.05 mgldl) levels in rats with
five-eighths nephrectomy, when compared to sedentary rats
with a similar degree of renal ablation. Whether the lower levels
of BUN and serum creatinine observed in exercised rats reflect
preservation of renal function or are due to other mechanisms
Table 1. Influence of dietary protein intake on GFR and effective
renal plasma flow in normal humansa
Diet
(g protein/kg body weight/day)
GFR
(mi/mm)
ERPF
(mi/mm)
2.3 to 3.0 117.3 4.3 640.2 18.5
1.0 to 1.4 104.2 2.9 570.8 17.6
O.ltoQ.4 95.2± 3.1 538.2±21.1
Abbreviation: ERPF, effective renal plasma flow.
a Data are mean and SEM. The table is adapted from Pullman et al
[50].
remains to be established. Both heparin and warfarin administra-
tion prevent the development of glomerular sclerosis and renal
insufficiency in rats with partial renal ablation [40, 49]. Thus, it
appears that coagulation may play a role in the deterioration of
renal function in partially nephrectomized rats. Whether antico-
agulant administration or endurance exercise training attenu-
ates the progression of kidney disease in these rats by prevent-
ing the development of hyperfiltration is not known.
Influence of dietary protein intake on renal function in
humans
Pullman et a! [50] found that GFR and effective renal plasma
flow decreased when normal individuals were fed a low protein
diet and both increased with a high protein diet. Table 1
summarizes the results of these studies. On the other hand,
Nielson and Bank [51] reported that inulin and iodopyracet
(Diodrast) clearances in normal subjects were relatively unaf-
fected by changes in dietary protein. Sargeant and Johnson [52]
found a reduction in GFR, measured by creatinine clearance, in
normal subjects fed a calorie-deficient diet. In both adults and
children with protein-calorie malnutrition a decrease in GFR
and renal plasma flow has been described [53]. Klahr and
Alleyne [54] found decreased values for GFR and renal plasma
flow in ten adults with protein malnutrition. Both GFR and
renal plasma flow increased significantly after protein repletion
[54].
These observations indicate that in humans a high intake of
protein will increase renal blood flow and GFR, thus producing
hyperperfusion and hyperfiltration, findings which are similar
to those obtained in experimental animals.
Role of phosphorus intake on the progression of renal disease
Several publications suggest a deleterious effect of high
phosphate intake on renal function [55—581. Haut et al [59]
confirmed these earlier reports and also found that, as renal
mass is reduced, renal damage is intensified and less phosphate
intake is required to induce renal injury. Normal rats fed a 2%
phosphate diet had no change in renal function, whereas
uninephrectomized and partially nephrectomized animals fed a
similar diet had a marked deterioration in renal function. In
general, it has been assumed that the pathogenesis of tissue
injury in hyperphosphatemia results from calcium-phosphate
deposition which leads to an inflammatory and fibrotic response
in a variety of tissues [60, 61]. A number of results, however,
suggest that there may be other mechanisms by which a high
phosphate intake can cause renal injury. First, the histologic
appearance of the calcium-phosphate deposits suggest they
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result from intrarenal mechanisms [56]. Second, the kidney
appears to calcify early during the course of renal failure before
plasma phosphorus concentrations are elevated, whereas other
organs in the uremic patient calcify in the terminal phase of
renal insufficiency when there are markedly increased concen-
trations of serum phosphorus [62, 63]. Thus, it has been
suggested that phosphorus-induced renal injury is mediated
through calcium-phosphate deposition in the kidney resulting
presumably from increased phosphate excretion per nephron
[64].
Gimenez et a! [65] found that male rats with a 70% reduction
of renal mass fed a diet containing 2.2% phosphate had a
progressive increase in serum creatinine to values, at 2 weeks
after surgery, fourfold higher than the mean values in compara-
bly partially nephrectomized animals fed a diet of normal
phosphate content. This deterioration in renal function was
associated with extensive nephrocalcinosis, cellular necrosis,
and marked interstitial inflammation. The administration of 3-
phosphocitric acid, a compound which prevents calcium-phos-
phate crystal growth and in vivo nephrocalcinosis, prevented
the decrease in renal function, the increase in renal calcium
content, and the histological changes observed in animals fed a
high phosphate diet.
The finding that increased phosphate intake may induce renal
damage raised the possibility that decreased phosphate intake
in animals or humans with renal insufficiency may be protec-
tive. In 1978 Ibels et al [661 reported that dietary restriction of
phosphate prevented proteinuria, renal calcification, histologic
changes, and functional deterioration and death from uremia in
rats with one and three-fourths nephrectomy. Animals fed a diet
of normal calcium and phosphate content showed renal deposi-
tion of calcium and phosphorus in cortical tubular cells, base-
ment membrane, and interstitium. Phosphate restriction mark-
edly decreased the amount of calcium and, phosphate deposited
in the kidney. In this study rats fed a phosphate-restricted diet
had a mean serum phosphorus of 3.4 0.3 mgldl, whereas, rats
fed a normal phosphorus diet had a serum phosphorus of 11.2
1.1 mgldl. Thus, uremic rats fed a phosphate-restricted diet and
aluminum hydroxide were severely hypophosphatemic since
serum phosphate levels in normal rats usually exceed 6 mg/di
and uremic rats have even higher values (8 to 12 mg!dl). Severe
hypophosphatemia may: (1) blunt tissue hypertrophy of the
remnant kidney and prevent the development of hyperfiltration;
(2) prevent the development of secondary hyperparathyroidism
and the lipid abnormalities that occur in this experimental
model; and (3) decrease cardiac output [67] and ameliorate the
hypertension which develops in rats with renal insufficiency.
Therefore, although phosphate restriction may prevent the
progression of renal insufficiency through a decrease in calci-
um-phosphate deposition in the kidney, other factors may also
explain the amelioration of renal deterioration in this particular
model.
Purkerson and Klahr (unpublished observations) have exam-
ined the effects of reducing phosphate intake in five-sixths
nephrectomized rats. After being nephrectomized, the rats
were fed a diet containing either 12 or 63 mg of phosphorus per
day for 4 weeks. This latter intake of phosphate does not
require an increased phosphaturia per nephron to maintain
phosphate balance in these rats. Table 2 shows data for blood
pressure, and blood levels of urea, creatinine, calcium, magne-
sium, and phosphate in the two groups of rats. Only the levels
of serum calcium and magnesium were significantly higher in
the rats fed a phosphorus-restricted diet as compared to rats
ingesting a normal diet. Renal function as assessed by serum
levels of creatinine and BUN were not significantly different
between the two groups of rats. On the other hand, as shown in
Table 3, there was a significant increase in the calcium and
phosphate content of the viable portion of the remnant kidney
in rats fed a normal phosphate diet when compared to rats fed a
phosphate-restricted diet. Thus, dietary phosphate restriction
prevents calcification of the viable portion of the remnant
kidney. We have not, as yet, examined the long-term effects (18
to 24 weeks) of preventing renal calcification on function to
determine whether or not it contributes to the progression of
renal disease in this model at later stages.
Recently, Laouari et a! [68] have re-examined the effect of a
low phosphorus diet in rats with seven-eighths nephrectomy.
They found that rats fed a diet markedly deficient in phosphorus
had marked anorexia, growth arrest, severe hypophosphatemia
and rickets, and renal function stabilized, probably as a conse-
quence of decreased total food intake. On the other hand, a
phosphate-restricted diet, such as to prevent the increased
phosphaturia and hyperparathyroidism of renal failure without
causing anorexia or other side effects had little or no beneficial
effect on the deterioration of renal function. Thus, preservation
of renal function in seven-eighths nephrectomized rats fed a low
phosphorus diet is mainly mediated by reduced ingestion of
some other component of the diet and not by phosphorus
restriction per se.
Karlinsky et al [69] also examined the effects of phosphorus
restriction in rats with nephrotoxic serum nephritis. Phosphate
restriction initiated 30 days after the administration of nephro-
toxic serum, when the rats had a well established autologous
phase proteinuria, prevented renal calcification, histologic dam-
age, and functional deterioration but had no apparent effect on
proteinuria [69]. To determine whether the protective effect of
phosphate restriction in this model was due to suppression of
parathyroid hormone secretion, thyroparathyroidectomy
Table 2. Blood pressure and blood levels (mg/dl) of urea, creatinine, calcium, magnesium, and phosphorus in five-sixths nephrectomized rats
fed a normal or decreased phosphorus dieta
BP
Diet mm Hg BUN Creatinine Ca Mg Pi
Normal Pi 119 8 54.3 6.8 2.19 0.25 9.3 0.28 1.88 0.9 8.21 0.5
Decreased Pi 129 8 62.7 12 1.96 0.29 10.6 0.25 2.34 0.15 6.93 2.0
P NS NS NS <0.01 <0.05 NS
Abbreviations: BP, blood pressure; Pi, phosphorus.
a These values represent the mean and SEM of six rats in each group. The animals were pair-fed.
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Table 3. Weight and mineral content of the viable portion of the remnant kidney in five-sixths nephrectomized rats fed a normal or decreased
phosphorus intakes
Diet
Kidney weight, giwet wt Dry tissue weight (viable portion) mg/g
Total
Viable
portion Infarcted Ca Mg Pi
Normal Pi
Decreased Pi
P
0.99 0.08
0.83 0.02
<0.05
0.53 0.04
0.58 0.03
NS
0.46 0.05
0.25 0.02
<0.05
4.02 1.42
0.75 0.28
<0.05
1.13 0.12
0.99 0.04
NS
25.07 3.53
14.22 0.32
<0.02
Abbreviations: BP, blood pressure; Pi, phosphorus.
These values represent the mean and SEM of six rats in each group. The animals were pair-fed.
(TPTX) was performed before and after the induction of neph-
rotoxic serum nephritis [70]. TPTX prevented functional deteri-
oration, proteinuria, renal calcification, and histologic change.
Selective parathyroidectomy had no protective effect on renal
function, proteinuria, or histologic damage. Thyroidectomy
alone was as protective as TPTX in this model. Rats given
thyroid replacement after TPTX had histological changes and
progression of renal failure comparable to that seen in control
animals. This suggests that thyroid hormone plays a role in the
progression of disease in this model. It should be stressed that
thyroid hormone is indispensable for renal growth and hyper-
trophy [71, 72]. Thus, similar to hypophosphatemia, thyroid
deficiency may prevent hyperfiltration and hemodynamic
changes which may occur in this model of nephrotoxic serum
nephritis.
Role of lipids in the progression of chronic renal disease
In a recent editorial, Moorhead et al [73] suggested a potential
role for plasma lipids in the progression of chronic renal
disease. It is known that levels of total cholesterol, triglycer-
ides, and phospholipids are increased in the nephrotic syn-
drome, and more so at lower albumin concentrations. The
mechanisms of hyperlipidemia in the nephrotic syndrome are
not completely clear but may relate to increased synthesis of
lipoproteins by the liver and loss of lipoprotein lipase activator,
such as apoprotein C2, in the urine [74]. It is of interest that
apoproteins, which function as carriers for lipids, have specific
receptors on the surface of various cells including fibroblasts,
smooth muscle cells, and lymphocytes [75]. Cells with recep-
tors for apoproteins B and E are able to ingest the lipoprotein
after which the protein moiety is broken down to amino acids
while the liberated cholesterol is involved in intracellular cho-
lesterol metabolism. At physiological pH and ionic strength
some lipoproteins (VLDL and LDL) can bind with polyanionic
glycosaminoglycans [76] which are major constituents of the
glomerular basement membrane. Potentially, therefore, lipo-
proteins may alter the permeability of the glomerular barrier by
binding with charges in the membrane. An increase in basement
membrane total lipids of up to 75% has been noted in glomerulo-
nephritis; a twofold increase in basement membrane lipids with
a fivefold increase in cholesterol has been observed in trans-
planted kidneys [77]. Moorhead et al [73] postulated that if in
the nephrotic syndrome lipoproteins are filtered in excessive
amounts and if mesangial cells possess receptors for apopro-
teins these cells will be able to ingest lipids. This may lead to
proliferation of mesangial cells and deposition of excess base-
ment membrane material. Mesangial cell proliferation is corn-
mon in glomerulonephritis; and crescent formation, in which
macrophage proliferation has been implicated, could also result
from lipoprotein stimulation. Moorhead et al [73] cited clinical
examples in humans and animals in which abnormalities in
lipids may be involved in the progression of renal disease. In
humans the rare syndrome of familial lecithin:cholesterol acyl-
transferase (LCAT) deficiency is characterized by an abnormal
serum LDL fraction and kidney disease which progresses to
renal failure. However, Gjone, Blomhoff, and Skarbovik [78]
described a patient with familial LCAT deficiency and normal
kidney function in whom the LDL level was also unexpectedly
normal, and they inferred a link between abnormal LDL levels
and renal disease in other patients with this familial LCAT
deficiency. The syndrome of partial lipodystrophy in humans is
also associated with glomerular changes which lead to renal
failure. However, no causal relationship has been established
between the glomerular pathology and the abnormalities of lipid
metabolism. In four patients with the nephrotic syndrome as a
complication of massive obesity, Weisinger et al [79] found that
dietary restriction was accompanied by weight loss and simulta-
neous remission in proteinuria and the nephrotic syndrome.
The serum cholesterol fell with dietary restriction, and when
the patients were given isocaloric high protein (120 to 180 g/day)
diets, no exacerbations of proteinuria were found. Edwards [80]
noted a significant inverse correlation between fasting serum
triglycerides and mean GFR in patients with analgesic nephrop-
athy. He also observed that renal transplant function was worse
in hypertriglyceridemic patients than in normolipernic controls.
Effects of manipulation of dietary lipids on the progression of
renal disease
Several reports suggest a role of dietary lipids in the progres-
sion of renal disease. Glomerular sclerosis was shown to develop
in guinea pigs fed a 1% cholesterol diet [81]. Hurd et al [82]
examined the effects of diets rich or deficient in essential fatty
acids on the progression of lupus nephritis in NZB/NZW hybrid
mice [83, 84]. These mice develop several immunologic abnor-
malities, as well as circulating immune complexes and immuno-
globulin deposition in the renal glomerulus. The severity of the
glomerulonephritis peaks at 9 months of age and causes death of
most animals by 12 months of age [83—85]. In Hurd's study a
group of mice was fed safflower oil which contains 78% linoleic
acid. Linoleic acid is a precursor of both eicosa-8,ll ,15-trienoic
(dihomo-y-linolenic) and eicosa-5 ,8, 11, lS-tetraenoic (arachi-
donic) acids which can be converted to prostaglandins, throm-
boxanes, prostacyclins, or leukotrienes. A second group of
animals was fed a normal chow diet. The third group of animals
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was fed the chow diet and was injected with PGE1. The fourth
group was fed a diet deficient in essential fatty acids (< 1%
linoleic acid). Animals fed this latter diet had markedly pro-
longed life, reduced severity of glomerulonephritis, and lower
levels of ANA and anti-DNA antibodies. Safflower oil had no
apparent beneficial effect on the severity of glomerulonephritis
or survival. POE1 treatment caused prolonged survival but was
less effective than an essential fatty acid deficient-diet in
reducing or preventing autoantibody production or the develop-
ment of glomerulonephritis. Although these studies did not
directly address the biochemical basis for the beneficial effects
of the essential fatty acid deficient diets on this model of lupus,
it is possible that one or more metabolites of arachidonic acid
may play a role in the pathogenesis of this disease. Products of
the lipooxygenase pathway (12-hydroxy-eicosatetraenoic acid,
1 2-hydroperoxy-eicosatetraenoic acid, leukotrienes, and so
forth) or cyclooxygenase pathway (prostacyclins, thrombox-
anes, prostaglandins, and so forth) could be involved in mediat-
ing murine lupus by virtue of their biological activity in chemo-
taxis, vascular permeability, and other factors involved in
inflammation [86, 871. Along similar lines, Prickett, Robinson,
and Steinberg [88] demonstrated that enrichment of the diet
with a polyunsaturated acid, eicosapentanoic acid, prevented
proteinuria and prolonged survival in NZB/NZW F1 mice.
Dietary eicosapentanoic acid (EPA, C20:5), a fatty acid analog
of arachidonic acid (C20:4), has been shown to impair platelet
aggregation in humans apparently through inhibition of the
synthesis of prostaglandins and thromboxanes from arachidonic
acid. Animals from 4 weeks of age were fed diets containing
25% lipid supplied either as beef tallow or menhaden oil with
fatty acid analysis of less than 0.05 and 14.4% eicosapentanoic
acid, respectively. By 13 months of age mice on the beef tallow
diet had all developed proteinuria and the majority (six of nine)
had died with renal histologic examination revealing severe
glomerulonephritis. In contrast, none of ten mice fed menhaden
oil had developed proteinuria or died at this time. In a second
experiment using 50 mice of each dietary group, 56% of the beef
tallow group versus none of the menhaden oil group had
developed proteinuria at 9 months of age. These results demon-
strate that a diet high in eicosapentanoic acid prevents the
development of glomerulonephritis in NZBINZW F1 mice.
Different results were obtained by Barcelli, Weiss, and Pollak
[89] who examined the effects of administering diets with a high
or normal linoleic acid content to three-fourths nephrectomized
and sham-operated rats. Nephrectomized rats fed the normal
linoleic acid diet had progressive deterioration of renal function
with serum creatinine levels rising to 5.55 mg/dl by week 20. By
contrast, nephrectomized rats fed the high linoleic acid diet
maintained stable renal function (mean serum creatinine 0.97
mg/dl at week 20). Urinary protein excretion was significantly
lower and glomerular sclerosis was prevented in the rats fed the
high linoleic acid diet. No changes were observed in the levels
of blood pressure, serum cholesterol, or serum triglycerides as
an effect of the diet. Increased POE2 production in the renal
cortex of the rats fed the high linoleic acid diet may have had,
according to the authors, a protective effect on renal function in
this model of renal disease. Platelets and coagulation may play a
role in the progression of the renal disease in three-fourths
nephrectomized rats [40, 491. It is of interest that studies in rats
fed different concentrations of dietary linoleic acid (from 0 to
6%) have shown that increased amounts of linoleic acid were
associated with decreased susceptibility of platelets to throm-
bin-induced aggregation and prolongation of the clotting time of
platelet rich plasma [90]. These studies in rats confirm and
extend previous work showing that dietary saturated and poly-
unsaturated fatty acids had opposite effects on platelet func-
tions in humans. Similar results have been reported in rabbits.
Linoleic acid intake may also influence the progression of
diabetic retinopathy [91]. In a prospective study, half of 102
patients with newly discovered diabetes mellitus received a
linoleic acid-enriched diet (20 g of linoleic acids per 1000 kcal)
and the other haff a saturated fat diet (5 g of linoleic acid per
1000 kcal). After 5 years significantly less retinopathy and
radiographic abnormalities were observed in the group on the
linoleic acid rich diet. No significant changes in body weight
occurred in either group as a consequence of dietary
manipulations.
The studies described above indicate that changes in dietary
lipids may influence the progression of a variety of renal
diseases as well as the retinopathy of patients with diabetes, an
abnormality which is closely associated with diabetic glomeru-
lar sclerosis. The mechanisms by which changes in dietary
lipids may produce their beneficial effects is not clear. In
experimental lupus nephritis it appears that decreased produc-
tion of one or more metabolites of arachidonic acid has a
beneficial effect on the disease. This effect may be related to the
action of prostaglandins in immunological and/or inflammatory
processes. By contrast in the other entities increased synthesis
of arachidonic acid metabolites seem to play a beneficial role.
Whether or not changes in the synthesis of vasodilatory prosta-
glandins is responsible is not known. Of interest, however, is
the fact that exogenous administration of prostaglandins may
affect the course of renal disease in several animal models [92—
94]. Changes in dietary lipids may affect the physiology of
platelets, and if thrombosis is involved in the progression of
certain forms of renal disease, they may prevent the progres-
sion of the disease by impairing the ability of platelets to
aggregate [95].
Regarding a potential role of prostaglandins in the progres-
sion of chronic renal disease, it is of interest that two groups
have reported an increased excretion of urinary prostaglandins
of theE2 series in patients with chronic renal disease. Suzuki et
al [96] found that urinary excretion of POE2 averaged 337 63
ng/24 hr in 25 female renal patients, a value significantly higher
than values obtained in 38 normal females (166 17 ng/24 hr).
Blum et al [97] found increased excretion of prostaglandins in
the urine of 13 males and 7 females with chronic glomerulone-
phritis or chronic interstitial nephritis. Kirschenbaum and Ser-
ros [981 studied the effects of prostaglandin inhibition of GFR in
rabbits with reduced renal mass. Administration of cyclooxy-
genase inhibitors to normal rabbits reduced urinary prostaglan-
din excretion by 53% without a change in creatinine clearance,
In contrast, administration of cyclooxygenase inhibitors to
uremic animals decreased urine prostaglandin excretion by 71%
and creatinine clearance by 50%. In these rabbits, urine prosta-
glandin excretion was twice that seen in normal rabbits and
when factored by either GFR or remaining renal mass, mean
values were nine times and four times, respectively, those seen
in normal animals. These findings suggest that intact renal
prostaglandin biosynthesis is necessary for the maintenance of
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GFR in animals with decreased renal mass. Similarly, Kimberly
et al [99] reported reduced renal blood flow and GFR in seven
patients with systemic lupus erythematosus associated with the
administration of aspirin. All of these patients had elevated
urine prostaglandin excretion prior to aspirin treatment suggest-
ing that prostaglandins were important in maintaining GFR in
the face of renal disease. These studies raise the question as to
the potential adverse effects that administration of nonsteroidal
anti-inflammatory agents may have in the progression of chron-
ic renal disease independent of their effects as analgesic nephro-
toxins [100].
In summary, although the observations reported are provoca-
tive and suggest a potential role for lipids in the progression of
renal disease, the evidence obtained is only circumstantial. A
cause-effect relationship has not been clearly established and
substantial additional work will be required to unravel the
potential mechanisms by which lipids may participate in the
progression of chronic renal disease.
Conclusions
The available evidence indicates a pronounced effect of
protein intake on the deterioration of renal function in several
widely differing experimental models of renal disease in rats and
mice. The evidence that similar effects occur in humans is
suggestive but tenuous. Although the "hyperfiltration theory"
provides a logical explanation for a link between dietary protein
intake and the progressive loss of renal function, the mecha-
nisms by which decreases in protein intake may attenuate the
progression of renal disease have not been unequivocally
established. Decreases in protein intake may modify immuno-
logical events, decrease hypertrophy and hyperfiltration in
remaining nephrons, affect lipid metabolism, prevent abnormal-
ities in coagulation, alter hormonal secretion and/or effects. All
of these factors alone or in combination may play a role in the
progression of renal disease. In addition, studies are required to
determine "safe" limits for protein restriction so as to avoid
prolonged negative nitrogen balance and malnutrition. The
evidence for a role of dietary phosphate in the progression of
renal disease is not compelling. The potential role of lipids,
although suggestive, is not conclusive. It is possible that each
one, protein, phosphate and lipid content of the diet, plays a
role in the progression of renal disease. The relative importance
of these dietary components may vary depending on the patho-
genesis, stage, and mechanisms of progression of any given
renal disease. The implications that dietary manipulations may
halt or delay the progression of renal disease are enormous. The
time is ripe for adequately controlled prospective studies in
humans to test the validity of some of the hypotheses proposed.
Such studies should carefully consider not only the criteria
needed to evaluate the effect of dietary manipulations on the
course of renal disease but also the nutritional requirements and
current intakes of protein, phosphate, and fatty acids in
humans.
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